Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Xvivo Perfusion AB

Closing information (x1000 DKK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 534,124 Less Arrow 401,354 Less Arrow 277,512
Financial expenses 23,321 More Arrow 31,087 More Arrow 37,216
Earnings before taxes 129,858 Less Arrow 63,487 Less Arrow 14,911
EBITDA 101,171 Less Arrow 43,052 Less Arrow 32,460
Total assets 1,560,481 Less Arrow 1,474,736 Less Arrow 1,158,104
Current assets 528,059 More Arrow 555,075 Less Arrow 312,404
Current liabilities 115,285 Less Arrow 90,332 Less Arrow 90,142
Equity capital 1,400,737 Less Arrow 1,306,437 Less Arrow 955,664
- share capital 523 More Arrow 541 Less Arrow 509
Employees (average) 158 Less Arrow 130 Less Arrow 114

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 89.8% Less Arrow 88.6% Less Arrow 82.5%
Turnover per employee 3,381 Less Arrow 3,087 Less Arrow 2,434
Profit as a percentage of turnover 24.3% Less Arrow 15.8% Less Arrow 5.4%
Return on assets (ROA) 9.8% Less Arrow 6.4% Less Arrow 4.5%
Current ratio 458.0% More Arrow 614.5% Less Arrow 346.6%
Return on equity (ROE) 9.3% Less Arrow 4.9% Less Arrow 1.6%
Change turnover 146,046 Less Arrow 122,413 Less Arrow 104,850
Change turnover % 38% More Arrow 44% More Arrow 61%
Chg. No. of employees 28 Less Arrow 16 More Arrow 22
Chg. No. of employees % 22% Less Arrow 14% More Arrow 24%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.